 |
 |
 |
 |
 |
 |
 |
Our
Portfolio CompaniesPlease
select an industry below for a detailed listing Health Care Information Technology
|
Animas designs, manufactures and markets products and services for patients with insulin-requiring diabetes. Its mission is to improve the lifestyle of patients, reduce the long-term morbidity of the disease and lower costs to patients and the health care system. Animas was acquired by Johnson & Johnson in February 2006. Aspect Medical Systems (NASDAQ: ASPM) is recognized as a pioneer and global market leader in brain monitoring, having led the way to develop proprietary technologies and ultimately improve the quality and cost effectiveness of patient care. BioProcessors provides SimCell solutions to biotechnology and pharmaceutical companies with a proven platform to exponentially increase experimental throughput and to enable scalability to production bioreactors at optimized yields. Ciphergen (NASDAQ: CIPH) is a leading provider of enabling tools and collaborative services in the emerging field of protein-based biology research, known as proteomics. Ciphergen develops and manufactures a ProteinChip® System that helps researchers understand the role of proteins in the biology of disease, such as monitoring disease progression and the therapeutic effects of drugs. Confluent Surgical markets synthetic, polymer-based, sprayable adhesion barriers and surgical sealants. These materials have potential applications across minimally invasive surgery in adhesion prevention, as sealants and hemostats, and in interventional procedures. Confluent was sold to the U.S. Surgical division of Tyco International in August 2006. EXACT Sciences Corporation (NASDAQ: EXAS) is an applied genomics company whose mission is to play a leading role in the eradication of common cancers by applying advances in the field of genomics to facilitate early detection of disease. Guava Technologies, Inc. is a biotechnology company that develops, manufactures and markets unique, high-impact cellular analysis systems for the life science research marketplace. Guava's patented technology has revolutionized the way scientists perform cell-based analysis.
IntelliDx, Inc. is a development stage medical device company focused on the commercialization of an automated blood glucose monitoring device. Pathway Medical Technologies, Inc. designs, develops and manufactures innovative medical devices intended for the treatment of arterial disease with a major focus on peripheral artery disease. Praecis Pharmaceuticals (NASDAQ: PRCS) is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAPTM (Ligand Evolution to Active Pharmaceuticals) technology. The company is currently targeting the treatment of prostate cancer, endometriosis and Alzheimer's disease. Satiety develops minimally invasive devices to treat obesity and certain other gastrointestinal conditions. Soteira, Inc. is developing a system for treatment of vertebral compression fractures in patients with osteoporosis, cancer or traumatic injuries. Soteira’s design provides a superior biomechanical structure and better control of cement flow than competing solutions. Spinal Concepts provides the surgical community with the most technologically advanced implants used in the treatment of spinal disorders, diseases and injuries. The company is a leader in technology with more than 40 U.S. patent awards, 22 foreign patents and numerous additional patents pending on product innovations. Spinal Concepts was sold to Abbott Laboratories in 2003. Spinal Kinetics Develops innovative and practical motion preservation systems for treating degenerative diseases of the spine. Valeritas develops proprietary drug delivery systems for Type 2 diabetes and metabolic diseases.
|
